Record revenues and a successful cortrophin gel launch have left ANI Pharmaceuticals, Inc. in high spirits following the second quarter of 2022, somewhat tempered by an increase in operational expenses for the firm.
“Second quarter net revenues of $73.9m represent a new quarterly record for the company, driven by the first full quarter...







